Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Agios Pharm

AGIO
Current price
46.61 USD -1.07 USD (-2.24%)
Last closed 47.68 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 2 604 745 216 USD
Yield for 12 month +69.37 %
1Y
3Y
5Y
10Y
15Y
AGIO
21.11.2021 - 28.11.2021

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias. The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts. Address: 88 Sidney Street, Cambridge, MA, United States, 02139

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

54.2 USD

P/E ratio

Dividend Yield

Current Year

+26 823 000 USD

Last Year

+14 240 000 USD

Current Quarter

+8 189 000 USD

Last Quarter

+7 103 000 USD

Current Year

+17 319 000 USD

Last Year

+12 536 000 USD

Current Quarter

+6 214 000 USD

Last Quarter

+5 114 000 USD

Key Figures AGIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -386 764 992 USD
Operating Margin TTM -1124.34 %
PE Ratio
Return On Assets TTM -24.55 %
PEG Ratio
Return On Equity TTM -39.61 %
Wall Street Target Price 54.2 USD
Revenue TTM 29 403 000 USD
Book Value 13.11 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 46 %
Dividend Yield
Gross Profit TTM 12 536 000 USD
Earnings per share -6.31 USD
Diluted Eps TTM -6.31 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics AGIO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AGIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation AGIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 2.4655
Enterprise Value Revenue 35.5852
Price Sales TTM 61.8241
Enterprise Value EBITDA -2.4801
Price Book MRQ 2.0461

Financials AGIO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AGIO

For 52 weeks

19.8 USD 49.06 USD
50 Day MA 40.09 USD
Shares Short Prior Month 4 224 594
200 Day MA 29.03 USD
Short Ratio 2.9
Shares Short 3 130 120
Short Percent 5.59 %

Dynamics of changes in the value of assets

A

ANN

26.72 AUD Ansell Ltd +0.25 (+1.4%)
Detailed analytics
Y

YUEIY

7.68 USD Yue Yuen Industrial Holdings -0.37 (-4.6%)
Detailed analytics
0

0MGV

96.33 EUR Eramet SA 0 (0%)
Detailed analytics
V

VTSCY

13.01 USD Vitesco Technologies Group Aktiengesellschaft +0.01 (+0.08%)
Detailed analytics
P

PATK

117.94 USD Patrick Industries Inc -1.16 (-0.97%)
Detailed analytics